157 related articles for article (PubMed ID: 26648547)
1. RhoA is associated with invasion and poor prognosis in colorectal cancer.
Jeong D; Park S; Kim H; Kim CJ; Ahn TS; Bae SB; Kim HJ; Kim TH; Im J; Lee MS; Kwon HY; Baek MJ
Int J Oncol; 2016 Feb; 48(2):714-22. PubMed ID: 26648547
[TBL] [Abstract][Full Text] [Related]
2. miRNA-503 Promotes Tumor Progression and Is Associated with Early Recurrence and Poor Prognosis in Human Colorectal Cancer.
Noguchi T; Toiyama Y; Kitajima T; Imaoka H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Toden S; Kusunoki M
Oncology; 2016; 90(4):221-31. PubMed ID: 26999740
[TBL] [Abstract][Full Text] [Related]
3. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
[TBL] [Abstract][Full Text] [Related]
4. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.
Mu Y; Zou H; Chen B; Fan Y; Luo S
Biomed Pharmacother; 2017 Jun; 90():548-554. PubMed ID: 28407575
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of formin-like 3 contributes to metastasis and poor prognosis in colorectal carcinoma.
Zeng YF; Xiao YS; Lu MZ; Luo XJ; Hu GZ; Deng KY; Wu XM; Xin HB
Exp Mol Pathol; 2015 Apr; 98(2):260-7. PubMed ID: 25758200
[TBL] [Abstract][Full Text] [Related]
6. Effect of StarD13 on colorectal cancer proliferation, motility and invasion.
Nasrallah A; Saykali B; Al Dimassi S; Khoury N; Hanna S; El-Sibai M
Oncol Rep; 2014 Jan; 31(1):505-15. PubMed ID: 24253896
[TBL] [Abstract][Full Text] [Related]
7. RacGAP1 expression, increasing tumor malignant potential, as a predictive biomarker for lymph node metastasis and poor prognosis in colorectal cancer.
Imaoka H; Toiyama Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Carcinogenesis; 2015 Mar; 36(3):346-54. PubMed ID: 25568185
[TBL] [Abstract][Full Text] [Related]
8. ITGBL1 promotes migration, invasion and predicts a poor prognosis in colorectal cancer.
Qiu X; Feng JR; Qiu J; Liu L; Xie Y; Zhang YP; Liu J; Zhao Q
Biomed Pharmacother; 2018 Aug; 104():172-180. PubMed ID: 29772438
[TBL] [Abstract][Full Text] [Related]
9. Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer.
Yan H; Hu K; Wu W; Li Y; Tian H; Chu Z; Koeffler HP; Yin D
PLoS One; 2016; 11(8):e0159954. PubMed ID: 27532268
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of IQGAP1 in advanced colorectal cancer correlates with poor prognosis-critical role in tumor invasion.
Hayashi H; Nabeshima K; Aoki M; Hamasaki M; Enatsu S; Yamauchi Y; Yamashita Y; Iwasaki H
Int J Cancer; 2010 Jun; 126(11):2563-74. PubMed ID: 19856315
[TBL] [Abstract][Full Text] [Related]
11. Solute carrier organic anion transporter family member 4A1 (SLCO4A1) as a prognosis marker of colorectal cancer.
Ban MJ; Ji SH; Lee CK; Bae SB; Kim HJ; Ahn TS; Lee MS; Baek MJ; Jeong D
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1437-1447. PubMed ID: 28378090
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of LAMC2 predicts poor prognosis in colorectal cancer patients and promotes cancer cell proliferation, migration, and invasion.
Huang D; Du C; Ji D; Xi J; Gu J
Tumour Biol; 2017 Jun; 39(6):1010428317705849. PubMed ID: 28653882
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.
Okugawa Y; Toiyama Y; Toden S; Mitoma H; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
Gut; 2017 Jan; 66(1):107-117. PubMed ID: 26475630
[TBL] [Abstract][Full Text] [Related]
14. RNA interference against TRIM29 inhibits migration and invasion of colorectal cancer cells.
Xu W; Xu B; Yao Y; Yu X; Cao H; Zhang J; Liu J; Sheng H
Oncol Rep; 2016 Sep; 36(3):1411-8. PubMed ID: 27430345
[TBL] [Abstract][Full Text] [Related]
15. miR-206 is an independent prognostic factor and inhibits tumor invasion and migration in colorectal cancer.
Sun P; Sun D; Wang X; Liu T; Ma Z; Duan L
Cancer Biomark; 2015; 15(4):391-6. PubMed ID: 26406866
[TBL] [Abstract][Full Text] [Related]
16. Specific upregulation of RHOA and RAC1 in cancer-associated fibroblasts found at primary tumor and lymph node metastatic sites in breast cancer.
Rozenchan PB; Pasini FS; Roela RA; Katayama ML; Mundim FG; Brentani H; Lyra EC; Brentani MM
Tumour Biol; 2015 Dec; 36(12):9589-97. PubMed ID: 26142737
[TBL] [Abstract][Full Text] [Related]
17. SNORA71A Promotes Colorectal Cancer Cell Proliferation, Migration, and Invasion.
Zhang Z; Tao Y; Hua Q; Cai J; Ye X; Li H
Biomed Res Int; 2020; 2020():8284576. PubMed ID: 33083486
[TBL] [Abstract][Full Text] [Related]
18. GCF2/LRRFIP1 promotes colorectal cancer metastasis and liver invasion through integrin-dependent RhoA activation.
Ariake K; Ohtsuka H; Motoi F; Douchi D; Oikawa M; Rikiyama T; Fukase K; Katayose Y; Egawa S; Unno M
Cancer Lett; 2012 Dec; 325(1):99-107. PubMed ID: 22750095
[TBL] [Abstract][Full Text] [Related]
19. Reduced p16 expression correlates with lymphatic invasion in colorectal cancers.
Tada T; Watanabe T; Kazama S; Kanazawa T; Hata K; Komuro Y; Nagawa H
Hepatogastroenterology; 2003; 50(54):1756-60. PubMed ID: 14696398
[TBL] [Abstract][Full Text] [Related]
20. mTOR regulate EMT through RhoA and Rac1 pathway in prostate cancer.
Chen X; Cheng H; Pan T; Liu Y; Su Y; Ren C; Huang D; Zha X; Liang C
Mol Carcinog; 2015 Oct; 54(10):1086-95. PubMed ID: 25043657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
